LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/DePuy Synthes’ “Next-Generation” Shoulder System
Large Joints and Extremities

DePuy Synthes’ “Next-Generation” Shoulder System

February 23, 2013 2 min read Premium comments

Advertisement

DePuy Synthes’ “Next-Generation” Shoulder System
Global United Shoulder System. Courtesy: DePuy Synthes
Secondary

DePuy Synthes Joint Reconstruction has introduced the Global Unite Platform Shoulder Arthroplasty System.

According to a February 19, 2013 press release, the system enables surgeons to anatomically treat proximal humeral fractures and easily convert to a reverse total shoulder without compromising recognized biomechanical principles.

The system is a modular system that allows 72 different sizing configurations. A suture collar allows secure anatomic reconstruction of the tuberosities and helps return the shoulder to a natural anatomical position. The FDA granted 510(k) clearance of the system and is indicated for press-fit or cemented fixation and offers the only modular system to provide a suture collar, which helps with anatomical reconstruction.

The company describes the Global Unite as a next-generation platform shoulder arthroplasty system which offers:

  • Modular proximal bodies available in four sizes and three heights to promote anatomic restoration of humeral head height and tuberosity placement in a press-fit application
  • Modular suture collar that allows additional suture fixation and anatomic reconstruction of the tuberosities
  • Humeral heads that are available in sizes 40-56mm in both standard and eccentric configurations
  • Option to convert to the DELTA XTENDTM Reverse Shoulder Arthroplasty System without the use of a stack on adaptor, which may compromise biomechanics
  • Similar stem geometry to the clinically successful DELTA XTEND
  • Revision without removal of a well-fixed humeral stem

Joseph Ianotti, M.D., Ph.D., Chairman, Orthopaedic and Rheumatologic Institute, Cleveland Clinic, said that, “Shoulder pathology is exceptionally varied, and with the Global Unite system surgeons have a comprehensive and fully interchangeable system that affords flexibility and versatility designed to address patients’ needs. My personal experience with the system has been very positive. Having a system where the implant is easily convertible gives you confidence that you can restore your patient’s shoulder to a natural anatomical position.”

The system is available worldwide and is also compatible with the following DePuy Synthes Joint Reconstruction glenoid components:

  • Global Anchor Peg Glenoid
  • Global Steptech, Anchor Peg Glenoid

The company cautioned that the performance of shoulder replacements depends on age, weight, activity level and other factors. There are potential risks and recovery takes time. People with conditions limiting rehabilitation should not have this surgery. Only an orthopedic surgeon can determine if shoulder replacement is indicated based on an individual patient’s condition.

DePuy Synthes Joint Reconstruction is part of DePuy Synthes Companies of Johnson & Johnson.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy